Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Differential effects of ketoconazole, itraconazole and voriconazole on the pharmacokinetics of imatinib and its main metabolite GCP74588 in rat.

Lin G, Wang C, Qiu X, Wang Z, Han A, Xu T, Kan X, Hu G.

Drug Dev Ind Pharm. 2014 Dec;40(12):1616-22. doi: 10.3109/03639045.2013.838582. Epub 2013 Sep 20.

PMID:
24053419
2.

Pharmacokinetic interaction between ketoconazole and imatinib mesylate (Glivec) in healthy subjects.

Dutreix C, Peng B, Mehring G, Hayes M, Capdeville R, Pokorny R, Seiberling M.

Cancer Chemother Pharmacol. 2004 Oct;54(4):290-4. Epub 2004 May 8.

PMID:
15138710
3.

Differential effects of ketoconazole and primaquine on the pharmacokinetics and tissue distribution of imatinib in mice.

Soo GW, Law JH, Kan E, Tan SY, Lim WY, Chay G, Bukhari NI, Segarra I.

Anticancer Drugs. 2010 Aug;21(7):695-703.

PMID:
20629201
5.

Simultaneous quantitation of azole antifungals, antibiotics, imatinib, and raltegravir in human plasma by two-dimensional high-performance liquid chromatography-tandem mass spectrometry.

Jourdil JF, Tonini J, Stanke-Labesque F.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Mar 1;919-920:1-9. doi: 10.1016/j.jchromb.2012.12.028. Epub 2013 Jan 9.

PMID:
23384531
6.

The effect of apigenin on pharmacokinetics of imatinib and its metabolite N-desmethyl imatinib in rats.

Liu XY, Xu T, Li WS, Luo J, Geng PW, Wang L, Xia MM, Chen MC, Yu L, Hu GX.

Biomed Res Int. 2013;2013:789184. doi: 10.1155/2013/789184. Epub 2013 Nov 28.

8.

[Drug-drug interaction of antifungal drugs].

Niwa T, Shiraga T, Takagi A.

Yakugaku Zasshi. 2005 Oct;125(10):795-805. Review. Japanese.

9.
11.

Development of a liquid chromatography tandem mass spectrometry method for the simultaneous measurement of voriconazole, posaconazole and itraconazole.

Wadsworth JM, Milan AM, Anson J, Davison AS.

Ann Clin Biochem. 2017 Nov;54(6):686-695. doi: 10.1177/0004563216686378. Epub 2017 Feb 8.

PMID:
27941128
13.

A reference laboratory experience of clinically achievable voriconazole, posaconazole, and itraconazole concentrations within the bloodstream and cerebral spinal fluid.

Wiederhold NP, Pennick GJ, Dorsey SA, Furmaga W, Lewis JS 2nd, Patterson TF, Sutton DA, Fothergill AW.

Antimicrob Agents Chemother. 2014;58(1):424-31. doi: 10.1128/AAC.01558-13. Epub 2013 Nov 4.

14.

A simple high-performance liquid chromatography method for simultaneous determination of three triazole antifungals in human plasma.

Zhang M, Moore GA, Barclay ML, Begg EJ.

Antimicrob Agents Chemother. 2013 Jan;57(1):484-9. doi: 10.1128/AAC.00768-12. Epub 2012 Nov 12.

15.

Pharmacokinetic interaction of ketoconazole and itraconazole with ciprofloxacin.

Abou-Auda HS, Mustafa AA, Al-Humayyd MS.

Biopharm Drug Dispos. 2008 Jan;29(1):29-35.

PMID:
17943700
16.

Voriconazole increases while itraconazole decreases plasma meloxicam concentrations.

Hynninen VV, Olkkola KT, Bertilsson L, Kurkinen KJ, Korhonen T, Neuvonen PJ, Laine K.

Antimicrob Agents Chemother. 2009 Feb;53(2):587-92. doi: 10.1128/AAC.00530-08. Epub 2008 Nov 17.

17.

Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection.

Gordien JB, Pigneux A, Vigouroux S, Tabrizi R, Accoceberry I, Bernadou JM, Rouault A, Saux MC, Breilh D.

J Pharm Biomed Anal. 2009 Dec 5;50(5):932-8. doi: 10.1016/j.jpba.2009.06.030. Epub 2009 Jun 24.

PMID:
19608374
18.

The kinetic deuterium isotope effect as applied to metabolic deactivation of imatinib to the des-methyl metabolite, CGP74588.

Manley PW, Blasco F, Mestan J, Aichholz R.

Bioorg Med Chem. 2013 Jun 1;21(11):3231-9. doi: 10.1016/j.bmc.2013.03.038. Epub 2013 Apr 1.

PMID:
23611771
19.

Influence of itraconazole co-administration and CYP2D6 genotype on the pharmacokinetics of the new antipsychotic ARIPIPRAZOLE.

Kubo M, Koue T, Inaba A, Takeda H, Maune H, Fukuda T, Azuma J.

Drug Metab Pharmacokinet. 2005 Feb;20(1):55-64.

20.

Metronidazole leads to enhanced uptake of imatinib in brain, liver and kidney without affecting its plasma pharmacokinetics in mice.

Tan SY, Kan E, Lim WY, Chay G, Law JH, Soo GW, Bukhari NI, Segarra I.

J Pharm Pharmacol. 2011 Jul;63(7):918-25. doi: 10.1111/j.2042-7158.2011.01296.x. Epub 2011 May 19.

PMID:
21635257

Supplemental Content

Support Center